{"schema_version":"secwatch.filing_event.v1","accession":"0001516551-23-000073","form_type":"8-K","ticker":"SKYE","cik":"0001516551","company_name":"Skye Bioscience, Inc.","filed_at":"2023-09-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.165663+00:00","generated_at":"2026-06-10T22:45:34.056019+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Skye Bioscience announces 1-for-250 reverse stock split effective Sept 8, 2023","bullets":["Reverse split at 1:250 reduces outstanding shares from ~3.078B to ~12.3M.","Authorized shares reduced from 5B to 20M; ticker SKYE gets 'D' for 20 trading days.","No stockholder vote required; fractional shares rounded up to whole shares.","Effective Sept 8, 2023; new CUSIP 83086J200 for common stock.","Each holder's percentage ownership unchanged except for rounding adjustments."],"urls":{"canonical":"https://secwatch.observer/filing/0001516551-23-000073","json":"https://secwatch.observer/filing/0001516551-23-000073.json","markdown":"https://secwatch.observer/filing/0001516551-23-000073.md","text":"https://secwatch.observer/filing/0001516551-23-000073.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1516551/000151655123000073/0001516551-23-000073-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1516551/000151655123000073/skye-20230906.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T22:45:34.056019+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"060b51b73ddb5b24a02c5c44d486c0464e4833fb","claim":"Skye Bioscience, Inc.: Reverse stock split at a ratio of one-for-250 and reduction of authorized shares from 5,000,000,000 to 20,000,000, effective via Certificate of Change and Certificate of Correction (effective 2023-09-08).","evidence_excerpt":"On September 6, 2023, Skye Bioscience, Inc. (the “Company”) filed a Certificate of Change and Certificate of Correction with the Secretary of State of the State of Nevada, which will effect a reverse stock split (the “Reverse Split”), at a ratio of one-for-250, of the Company’s issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655123000073/0001516551-23-000073-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-09-08"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}